What are the recommended dosing regimens of Cremaffin (lactulose) and magnesium picosulfate for adults with hepatic encephalopathy or constipation and for children older than two years with constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dosing of Cremaffin (Lactulose) and Magnesium Picosulfate

Lactulose (Cremaffin) Dosing

For Adults with Constipation

Start lactulose at 15-30 mL (10-20 g or 1-2 packets) once daily, preferably in the evening, and titrate upward every few days to a maximum of 60 mL (40 g) daily based on stool response, aiming for 2-3 soft, non-forced bowel movements per day. 1, 2

Dosing algorithm:

  • Initial dose: 15-30 mL (10-20 g) once daily in the evening 1, 2
  • Titration: Increase dose every few days based on stool frequency and consistency 1
  • Maximum dose: 60 mL (40 g) daily 1, 2
  • Goal: Achieve 2-3 soft, non-forced bowel movements daily 3, 4

Position in treatment algorithm:

  • Lactulose is recommended as a second-line option for adults with chronic idiopathic constipation who have failed or are intolerant to over-the-counter therapies (fiber, polyethylene glycol) 1, 3
  • This is a conditional recommendation with very low certainty of evidence 1, 3

Common side effects to monitor:

  • Bloating and flatulence occur in approximately 20% of patients and are dose-dependent 3, 5
  • Abdominal cramping may occur, particularly at higher doses 3
  • Excessive dosing can cause diarrhea with potential hypokalemia and hypernatremia 3, 4

For Adults with Hepatic Encephalopathy

For acute hepatic encephalopathy, administer 30-45 mL (20-30 g) three to four times daily orally, or hourly until rapid laxation is achieved, then reduce to maintenance dosing. 2, 6

Acute encephalopathy dosing:

  • Initial rapid laxation: 30-45 mL hourly until stool evacuation occurs 2, 6
  • Maintenance: 30-45 mL (20-30 g) three to four times daily 2
  • Goal: Produce 2-3 soft bowel movements per day 2, 6

For deep encephalopathy (impending coma):

  • Administer via nasogastric tube or retention enema if oral route is not feasible 2, 6
  • Retention enema preparation: Mix 300 mL lactulose with 700 mL water or physiologic saline, retain for 30-60 minutes 2, 7
  • Repeat enema every 4-6 hours if needed 2

Chronic encephalopathy maintenance:

  • Dose to achieve 2-3 soft bowel movements per day 6
  • Continuous long-term therapy is indicated to prevent recurrence 2, 6

For Children Over Two Years with Constipation

For older children and adolescents, start with a total daily dose of 40-90 mL divided throughout the day, adjusting based on response to achieve 2-3 soft stools daily. 2

Pediatric dosing algorithm:

  • Infants: Initial dose 2.5-10 mL daily in divided doses 2
  • Older children and adolescents: 40-90 mL total daily dose 2
  • Titration: Adjust dose gradually based on symptom response and side effects 5
  • If diarrhea occurs: Reduce dose immediately; discontinue if diarrhea persists 2

Important pediatric considerations:

  • Allow 24-48 hours or longer for clinical response before increasing dose 5
  • Monitor for excessive gas, abdominal discomfort, and diarrhea (may be difficult to assess in preverbal children) 5
  • Lactulose is considered safe and well-tolerated in constipated children 5

Magnesium Picosulfate (Sodium Picosulfate) Dosing

For Adults with Constipation

Magnesium picosulfate (sodium picosulfate) is recommended for short-term use (4 weeks or less) or as rescue therapy, starting at lower doses and titrating upward as tolerated. 1

Key dosing principles:

  • Duration: Daily use for 4 weeks or less 1
  • Approach: Start at lower doses and increase as tolerated 1
  • Position: Best used for occasional use or rescue therapy in combination with other agents 1

Important limitations:

  • Sodium picosulfate tablets/drops are not available in the United States but are approved in Europe 1
  • In the US, sodium picosulfate is only available in combination products for bowel preparation before colonoscopy 1
  • Long-term safety and efficacy data are lacking; while long-term use is probably appropriate, more data are needed 1

Common side effects:

  • Abdominal pain and cramping 1
  • Diarrhea 1
  • Start at lower doses to minimize these effects 1

Critical Clinical Pitfalls to Avoid

For lactulose:

  • Do not use as first-line therapy before trying over-the-counter options (fiber, polyethylene glycol) for chronic constipation 3, 4
  • Avoid in patients with suspected mechanical bowel obstruction 3
  • Use caution with magnesium-based laxatives in renal insufficiency (CrCl <20 mg/dL), but lactulose has no such restriction 3
  • Monitor electrolytes (potassium, sodium) when using high doses, especially in elderly patients or those on diuretics 3, 4

For magnesium picosulfate:

  • Do not use as continuous daily therapy beyond 4 weeks due to insufficient long-term evidence 1
  • Reserve primarily for rescue therapy or breakthrough symptoms 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lactulosa-Associated Adverse Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Lactulose for Severe Constipation: Treatment Recommendation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Lactulose Dosing for Infant Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hepatic Encephalopathy.

The American journal of gastroenterology, 2001

Research

Lactulose enemas in the treatment of hepatic encephalopathy. Do we help or harm?

Revista espanola de enfermedades digestivas, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.